Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
NICE guidance on obesity principally NICE CG189 (Obesity: identification, assessment and management) and NICE PH53 (Weight management: lifestyle services for overweight or obese adults) recommends a combination of dietary modification, increased physical activity, and behavioural support as the cornerstone of weight management
Semaglutide (Wegovy) for the treatment of obesity or weight management should not be used during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm due to the potential hazard of maternal weight loss to the fetus
These injections are often used with L-Carnitine, Vitamin D, or NAD+ therapies for even greater support.
Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle
PMID 26385097
